BRL-44408 maleate is a selective antagonist of adrenergic receptors α2A/α2B. It effectively antagonizes the inhibitory effects of norepinephrine or the adrenergic receptor agonist clonidine on K⁺-induced [³H]norepinephrine and [³H]serotonin release. BRL-44408 exhibits higher affinity for human platelet membranes containing α2A-adrenergic receptors compared to BRL-41992 and imiloxan. It may modulate norepinephrine and serotonin release via α2A-adrenergic receptor-mediated mechanisms, suggesting a potential role in the regulation of neurotransmitter release.